AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomes - Junya Peng; Rui Jiang; Jiajuan Tu; Wanli Liu; Lu Ping; Ruikang Dun; Wenyu Zhang; Hao Chen; Yihong Shi; Xu Pan; Panpan Jia; Mengjie Li; et al. (Science Bulletin, 2026)

PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial - Si-Yang Maggie Liu; Jie Huang; Jia-Yi Deng; Chong-Rui Xu; Hong-Hong Yan; Ming-Yi Yang; Yang-Si Li; E-E Ke; Ming-Ying Zheng; Zhen Wang; Jia-Xin Lin; Bin Gan; et al. (Science Bulletin, 2024)

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis - Jie Xiong; Yu-Ting Dai; Wen-Fang Wang; Hao Zhang; Chao-Fu Wang; Tong Yin; Shu Cheng; Hui-Juan Zhong; Shan-He Yu; Lu Jiang; Sheng-Yue Wang; Hai Fang; et al. (Science Bulletin, 2023)